News

UNITE4TB, the largest public-private collaboration in tuberculosis drug development, announces start of clinical trials, including the UCSF-designed PARADIGM4TB adaptive clinical trial

Today, UNITE4TB, an international public-private partnership striving to fast-track the development of innovative Tuberculosis (TB) treatments, announced the start of its Phase 2B/C clinical trial program with the first participant enrolled at its trial site in Cape Town, South Africa.

In Honor of John Murray

TB RAMP Flyer Spring 2023

Congratulations to Mike Reid! Newly appointed Chief Science Officer at PEPFAR 

Highlight schedule from 2022 Union Conference & TB Science

As the Union Conference an

Postdoc Slam on September 21!

After a two-year hiatus, Postdoc Slam is back at UCSF, just in time for National Postdoc Appreciation Week!

SMART4TB: UCSF Joins $200 Million Global TB Consortium

SMART4TB Consortium WebsiteUSAID Funds research on tube

ATS Conference: TB-related talks and posters

DOWNLOAD SCHEDULE FOR TB-RELATED TALKS & POSTERS

Dr. Gustavo Velásquez featured in "The Dose" podcast

In honor of World TB Day, the Working Group on New TB Drugs (WGND) has rele

New publication, "Innovations for Tackling Tuberculosis in the Time of COVID-19"

The National Academies of Sciences, Engineering, and Medicine's Forum on Microbial